دورية أكاديمية

PCN103 PHARMACOECONOMIC ANALYSIS OF THE ADDITION OF RITUXIMAB TO FLUDARABINE-CYCLOPHOSPHAMIDE REGIMEN IN THE FIRST-LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKAEMIA PATIENTS IN SPAIN

التفاصيل البيبلوغرافية
العنوان: PCN103 PHARMACOECONOMIC ANALYSIS OF THE ADDITION OF RITUXIMAB TO FLUDARABINE-CYCLOPHOSPHAMIDE REGIMEN IN THE FIRST-LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKAEMIA PATIENTS IN SPAIN
المؤلفون: Bosch, F, Casado, LF, Garcia-Marco, JA, Gilsanz, F, Gonzalez Diaz, M, Rayon, C
المصدر: Value in Health ; volume 12, issue 7, page A276 ; ISSN 1098-3015
بيانات النشر: Elsevier BV
سنة النشر: 2009
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
مصطلحات موضوعية: Public Health, Environmental and Occupational Health, Health Policy
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/s1098-3015(10)74354-0
الإتاحة: https://doi.org/10.1016/s1098-3015Test(10)74354-0
https://api.elsevier.com/content/article/PII:S1098301510743540?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1098301510743540?httpAccept=text/plainTest
حقوق: https://www.elsevier.com/tdm/userlicense/1.0Test/ ; https://www.elsevier.com/open-access/userlicense/1.0Test/
رقم الانضمام: edsbas.373A0B49
قاعدة البيانات: BASE